Sunitinib 50 mg Capsule Abu Dhabi | Top Pharma Exporter from India

Sunitinib 50 mg Capsule: Comprehensive Guide for Global Bulk Supply

Are you searching for a dependable Sunitinib 50 mg capsule exporter from India? Ernest Oncology, a specialized division of Ernest Pharmaceutical Pvt. Ltd., is a leading international bulk supplier and distributor. We provide high-quality oncology solutions to the USA, UK (London), UAE (Abu Dhabi), Australia, and South Africa, ensuring timely delivery and professional B2B service.

Product Detail: What is Sunitinib 50 mg?

Sunitinib 50 mg (commonly known by the brand name Sutent or Sutinat) is an oral, multi-targeted receptor tyrosine kinase (RTK) inhibitor. The 50 mg strength is the highest standard dose, often used at the beginning of treatment cycles to aggressively manage tumor growth by inhibiting the blood supply and cellular signaling of cancer cells.

Therapeutic Indications

Sunitinib 50 mg is widely recognized for its efficacy in treating:

• Advanced Renal Cell Carcinoma (RCC): The primary treatment for advanced or metastatic kidney cancer.

• Gastrointestinal Stromal Tumor (GIST): Used when previous treatments like imatinib have failed or cannot be tolerated.

• Pancreatic Neuroendocrine Tumors (pNET): For progressive, well-differentiated tumors located in the pancreas.

• Adjuvant Treatment of RCC: For patients at high risk of recurrent kidney cancer following surgery (nephrectomy).

Pharmacology and Mechanism of Action

Sunitinib works by blocking several enzymes called Tyrosine Kinases. These enzymes are found in receptors on the surface of both cancer cells and normal cells.

1. Anti-Angiogenesis: It blocks VEGFR (Vascular Endothelial Growth Factor Receptors), preventing the tumor from developing the new blood vessels it needs to "feed" and grow.

2. Anti-Proliferation: It targets PDGFR (Platelet-Derived Growth Factor Receptors) and KIT, which are vital for the survival and division of cancer cells.

By attacking the cancer from multiple angles, Sunitinib 50 mg helps shrink tumors and delay the progression of the disease.

Dosage and Administration Schedule

• The 4/2 Cycle: For RCC and GIST, the standard protocol involves taking 50 mg once daily for 4 weeks ("on" period), followed by 2 weeks of rest ("off" period). This 6-week period constitutes one complete cycle.

• Continuous Dosing: For pNET, a lower daily dose (typically 37.5 mg) is often taken continuously without a rest period.

• Administration: Capsules must be swallowed whole with water. They can be taken with or without food.

Important Safety Information

Patients using Sunitinib 50 mg should be monitored for:

• Hypertension (High Blood Pressure): Blood pressure should be checked regularly.

• Hepatotoxicity: Liver function tests are required during treatment.

• Thyroid Dysfunction: Both hypothyroidism and hyperthyroidism can occur.

• Dermatological Effects: "Hand-foot syndrome" (redness and peeling of skin on extremities) or skin/hair yellowing.

Why Partner with Ernest Oncology for Sunitinib 50 mg?

• Strategic Global Logistics: Direct shipping to USA, UK, UAE, Australia, and South Africa. 

• Authentic Indian Exports: We source from reputable manufacturers (e.g., Natco Pharma, Pfizer, Shilpa Medicare), ensuring product integrity.

• Competitive B2B Pricing: Specialized pricing models for clinics, hospitals, and pharmacies.

• Expert Documentation: We handle all international pharmaceutical export regulations and customs paperwork.